NM_207346.3:c.285+32C>A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_207346.3(TSEN54):c.285+32C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.715 in 1,443,256 control chromosomes in the GnomAD database, including 351,199 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.65   (  24369   hom.,  cov: 29) 
 Exomes 𝑓:  0.72   (  326830   hom.  ) 
Consequence
 TSEN54
NM_207346.3 intron
NM_207346.3 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.00  
Publications
20 publications found 
Genes affected
 TSEN54  (HGNC:27561):  (tRNA splicing endonuclease subunit 54) This gene encodes a subunit of the tRNA splicing endonuclease complex, which catalyzes the removal of introns from precursor tRNAs. The complex is also implicated in pre-mRNA 3-prime end processing. Mutations in this gene result in pontocerebellar hypoplasia type 2.[provided by RefSeq, Oct 2009] 
TSEN54 Gene-Disease associations (from GenCC):
- pontocerebellar hypoplasia type 2AInheritance: AR Classification: STRONG Submitted by: PanelApp Australia
- pontocerebellar hypoplasia type 4Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia
- pontocerebellar hypoplasia type 5Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- pontocerebellar hypoplasia type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79). 
BP6
Variant 17-75517104-C-A is Benign according to our data. Variant chr17-75517104-C-A is described in ClinVar as Benign. ClinVar VariationId is 160133.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.738  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.647  AC: 79302AN: 122580Hom.:  24374  Cov.: 29 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
79302
AN: 
122580
Hom.: 
Cov.: 
29
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.601  AC: 114087AN: 189872 AF XY:  0.622   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
114087
AN: 
189872
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.722  AC: 952874AN: 1320614Hom.:  326830  Cov.: 43 AF XY:  0.724  AC XY: 473894AN XY: 654972 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
952874
AN: 
1320614
Hom.: 
Cov.: 
43
 AF XY: 
AC XY: 
473894
AN XY: 
654972
show subpopulations 
African (AFR) 
 AF: 
AC: 
5577
AN: 
16112
American (AMR) 
 AF: 
AC: 
15125
AN: 
34638
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
15005
AN: 
22748
East Asian (EAS) 
 AF: 
AC: 
17096
AN: 
35468
South Asian (SAS) 
 AF: 
AC: 
54588
AN: 
75846
European-Finnish (FIN) 
 AF: 
AC: 
34048
AN: 
46616
Middle Eastern (MID) 
 AF: 
AC: 
3543
AN: 
5150
European-Non Finnish (NFE) 
 AF: 
AC: 
770937
AN: 
1030298
Other (OTH) 
 AF: 
AC: 
36955
AN: 
53738
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.560 
Heterozygous variant carriers
 0 
 16588 
 33177 
 49765 
 66354 
 82942 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 19322 
 38644 
 57966 
 77288 
 96610 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.647  AC: 79303AN: 122642Hom.:  24369  Cov.: 29 AF XY:  0.645  AC XY: 38841AN XY: 60212 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
79303
AN: 
122642
Hom.: 
Cov.: 
29
 AF XY: 
AC XY: 
38841
AN XY: 
60212
show subpopulations 
African (AFR) 
 AF: 
AC: 
8141
AN: 
20740
American (AMR) 
 AF: 
AC: 
7028
AN: 
13234
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2078
AN: 
3106
East Asian (EAS) 
 AF: 
AC: 
2341
AN: 
4698
South Asian (SAS) 
 AF: 
AC: 
3117
AN: 
4406
European-Finnish (FIN) 
 AF: 
AC: 
7272
AN: 
9950
Middle Eastern (MID) 
 AF: 
AC: 
177
AN: 
262
European-Non Finnish (NFE) 
 AF: 
AC: 
47255
AN: 
63554
Other (OTH) 
 AF: 
AC: 
1139
AN: 
1784
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 1593 
 3187 
 4780 
 6374 
 7967 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 692 
 1384 
 2076 
 2768 
 3460 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Benign 
Submissions summary: Benign:9 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:4 
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided    Benign:2 
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Pontocerebellar hypoplasia type 2A    Benign:1 
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Pontocerebellar hypoplasia type 5    Benign:1 
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Pontocerebellar hypoplasia type 4    Benign:1 
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.